Small Cap Feast

22nd November 2023

Dish of the day
No Joiners today
Off the menu
No leavers today
Dish Of The Day:

No joiners today.

No leavers today.

What’s Cooking In The IPO Kitchen?

15 November: Afentra Plc ITF: Formerly Sterling Energy plc, and launched in 2021 to support the African energy transition as a independent oil and gas company announces its Admission to AIM pursuant to the Sonangol Acquisition which constitutes a reverse takeover and therefore Admission is being sought as a result of such reverse take-over. The Company will not be raising new capital as part of its Admission. Anticipated market capitalisation on Admission will be c.£65m. Expected Admission date is expected mid-December.

9 November: Chapel Down Group ITF:  England's leading and largest wine producer with an award-winning range of sparkling and still wines, under the Chapel Down brand. The Company owns, leases and sources from 1,023 acres of vineyards in South East England announces its Admission to AIM after its transfer from the Aquis Apex market. The Company will not be raising new capital or providing a secondary offering as part of its Admission. Anticipated market capitalisation on Admission will be c.£75m. Expected Admission date is 7 December 2023.

2 October: Tekcapital announced intention to spin off and IPO: MicroSalt, the developer of salt-producing technology designed to deliver full flavor with less sodium, announces the launch of an exempt public offer of shares to retail investors for up to £2.5m via PrimaryBid as part of its spin out from AIM listed Tekcapital plc (TEK.L). Microsalt announced revenues of US$0.638m in 2022, its first year of retail sales of SaltMe Crisp brand and Microsalt salt shakers in US based supermarkets and through Amazon US. AIM Admission delayed, expected mid-November.

Breakfast Buffet

Atlantic Lithium 26.58p £162.7m (ALL.L)
The African-focused lithium exploration and development company provides an update on its flagship Ewoyaa Lithium Project in Ghana, West Africa. Bulk Customer Permit was awarded in respect of the electricity requirements of the project, expected to deliver a 30-50% overall power cost reduction. Advanced discussions ongoing for the award of the Engineering, Procurement, Construction and Management (EPCM) contract for the main processing plant and all non-processing infrastructure. Award of the contract to divert the transmission lines is expected in Q2 2024.

Aurrigo International 102.5p £46.6m (AURR.L)
The international provider of transport technology solutions, has signed a Project Agreement with International Airlines Group, S.A. (IAG) for the deployment and demonstration of Aurrigo's autonomous aviation solutions at the Cincinnati/Northern Kentucky International Airport (CVG). The Partnership is expected to follow a similar phasing to Aurrigo's agreement with IAG in the UK with an evaluation and simulation phase to commence in November 2023 running for three months. The deployment of Aurrigo's vehicles under the Agreement will be undertaken at CVG and valued at $0.29m.

CleanTech Lithium 22.0p £23.1m (CTL.L)
The exploration and development company advancing sustainable lithium projects in Chile, announces that it has conditionally raised gross proceeds of £8m by issuing new shares at 22 pence per shares. The Placing comprises 14,124,466 Firm Placing Shares together with 7,062,233 Warrants, and 22,239,172 Conditional Placing Shares and 11,119,586 Warrants. Regal Funds, interested in more than 10% of the Company's issued share capital, has agreed to subscribe for approximately £1.2m , thereby maintaining its current interest in the Company on the enlarged basis. The new funds will be focused on the development of the Laguna Verde project and provide flexibility for additional drilling at Francisco Basin.

Duke Royalty 31.25p £131.7m (DUKE.L)
The provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, announces its interim results for the six-months ended 30 September 2023 (H1 FY24). Cash revenue increased 35% from the prior period to £14.1m (H1 FY23: £10.4m). Free cash flow was up 23% to £7.9 million (H1 FY23: £6.5 million). Adjusted earnings was up 23% to 1.95 pence per share (Interim 2023: 1.58 pence per share). The Company has over £40m of available liquidity for future deployments.

OptiBiotix Health 27.0p £24.6m (OPTI.L)
The life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces that the University of Reading has provided a grant under the Biotechnology and Biological Science Research Council (BBSRC) to fund a research project on WellBiome®, a new prebiotic and mineral complex. The research project will be carried out by the University of Leeds and provides £55k to assess the ability of WellBiome®. WellBiome® was launched in 2023 was part of a strategy to enhance OptiBiotix's range of product offerings and to mitigate the seasonal variations in the sale of weight management products.

Pebble Beach Systems Group 6p £7.5m (PEB.L)
The provider of digital commerce, products and related services to the global promotional products industry, provides a trading update for the year to 31 December 2023 (FY23). Group revenues for FY23 are expected to be approximately £124m, down 7% (FY22: £134m). As the Group has continued to generate stronger gross margins in FY23, the impact of the revenue reduction is expected to be partially mitigated. Group EBITDA is expected to be approximately £16m (FY 22: £18.0m). The Group expects net cash as at 31 December 2023 to be no less than prior year net cash of £15.1m, Strength of pipeline and level of customer engagement provides management with confidence in delivering full year growth.

Petards* 6.25p £3.5m (PEG.L)
The AIM quoted developer of advanced security and surveillance systems, announces the appointment of Geraint Davies, as an independent Non-Executive Director with immediate effect. Geraint Davies is a Fellow of the Institute of Chartered Accountants with over 30 years' experience, working with global national and local organisations in the private and public sector. Prior to his appointment, Geraint held senior leadership roles in EY's practices in the Channel Islands, the UK, and Europe, most recently in Malta. He has also previously held roles with PwC and Deloitte.

Quadrise 1.5525p £24.3m (QED.L)
The supplier of innovative energy solutions provides an update on its fuel trial following the announcement on 31 October 2023. The industrial demonstration test of MSAR® and bioMSAR™ fuels at the client's site in Morocco has been completed in accordance with the performance criteria of the agreement announced by the Company on 13 June 2022. The industrial unit in question was successfully operated at varying loads of up to 100%, equivalent to 33MW of energy that is supplied by a single burner. The final phase of combustion optimisation tests recently completed involved experts from Quadrise and the client fine-tuning combustion at full (100%) load and production rates using Quadrise fuels.

Redcentric 111.5p £174.m (RCN.L)
The UK-based IT managed services provider announces its unaudited results for the six months to 30 September 2023 (H1 FY24). Revenue grew by 33.3% to £82.0m (H1 FY23: £61.5m). Adjusted EBITDA was £14.5m (H1 FY23: £11.7m). Net debt increased by £1.7m since 31 March 2023 to £74.7m. Electricity conservation programmes completed post the period end with annualised savings of £2.8m. Further own-use electricity commodity contracts taken out with 100% of FY24 and 70% of FY25 anticipated volumes secured at fixed prices. The full benefits of reduced electricity commodity prices and the energy conservation programmes are expected from 1 April 2024 onward.

Ten Lifestyle Group 104p £88.3m (TENG.L)
The technology-enabled, global concierge platform, announces its preliminary results for the year ended 31 August 2023 (FY23). Net revenue increased 35% to £63.0m, (FY22: £46.8m), adjusted EBITDA was £12.0m (FY22: £4.9m), an 145% improvement. Profit before tax was £0.9m (FY22: loss £3.8m). Net cash was £3.7m (FY22: £3.2m). The Company plans to maintain investment in technology, communications, and content, which provides competitive advantage, with investment into AI and expects cash generation across FY24, with H2 being stronger than H1.

22 November 2023
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour


Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram